The Antioxidant Additive Approach for Alzheimer’s Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators - Archive ouverte HAL Access content directly
Journal Articles Journal of Medicinal Chemistry Year : 2016

The Antioxidant Additive Approach for Alzheimer’s Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators

, , , , , , , , , , , , , , , (1)
1
Mohamed Benchekroun
Alejandro Romero
  • Function : Author
Javier Egea
  • Function : Author
Rafael León
  • Function : Author
Patrycja Michalska
  • Function : Author
Izaskun Buendía
  • Function : Author
María Luisa Jimeno
  • Function : Author
Daniel Jun
Jana Janockova
Vendula Sepsova
  • Function : Author
Ondrej Soukup
Oscar Bautista-Aguilera
  • Function : Author
Bernard Refouvelet
  • Function : Author
Olivier Ouari
  • Function : Author
José Marco-Contelles
Not file

Dates and versions

hal-03654706 , version 1 (28-04-2022)

Identifiers

Cite

Mohamed Benchekroun, Alejandro Romero, Javier Egea, Rafael León, Patrycja Michalska, et al.. The Antioxidant Additive Approach for Alzheimer’s Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators. Journal of Medicinal Chemistry, 2016, 59 (21), pp.9967-9973. ⟨10.1021/acs.jmedchem.6b01178⟩. ⟨hal-03654706⟩

Collections

UNIV-FCOMTE
9 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More